Searchable abstracts of presentations at key conferences in endocrinology

ea0050p194 | Clinical Biochemistry | SFEBES2017

A well recognised but forgotten cause of undetectable Magnesium

Ahmad Sajjad , Akbar Saeed , George Lindsey , Evans Marc

A 74 years old man prsented with gradually worsening confusion with associated jerky movements with background of well controlled type 2 Diabetes, CKD-3, IHD and previous duodenal ulcer. His was on Finasteride, Omeprazole, Mirtazapine, Tamsulocin, Metformin, Atorvastatin, Humulin I insulin. He was taking omeprazole for Duodenal ulcer since 1993.On examination he had jerky movements of the arms suggestive of muscles spasms. Res...

ea0050p183 | Clinical Biochemistry | SFEBES2017

The free androgen index in women is inaccurate when the SHBG concentration is low

Keevil Brian , Adaway Joanne , Fiers Tom , Kaufman Jean-Marc

Introduction: Current clinical practice guidelines recognise that a calculated free testosterone (T) level is the single most-useful, clinically sensitive marker of androgen excess in women, but there is no clear guidance as to the best way to measure free T. Several equations have been proposed to calculate clinically useful estimates of free T including the free androgen index (FAI) and calculated free T (cFT). The FAI is not used in men but it is...

ea0050p194 | Clinical Biochemistry | SFEBES2017

A well recognised but forgotten cause of undetectable Magnesium

Ahmad Sajjad , Akbar Saeed , George Lindsey , Evans Marc

A 74 years old man prsented with gradually worsening confusion with associated jerky movements with background of well controlled type 2 Diabetes, CKD-3, IHD and previous duodenal ulcer. His was on Finasteride, Omeprazole, Mirtazapine, Tamsulocin, Metformin, Atorvastatin, Humulin I insulin. He was taking omeprazole for Duodenal ulcer since 1993.On examination he had jerky movements of the arms suggestive of muscles spasms. Res...

ea0086op6.1 | Endocrine Cancer and Late Effects | SFEBES2022

Post-Transcriptional regulation of wild-type and variant androgen receptors during prostate cancer progression

Lorentzen Marc , Powell Sue , Bevan Charlotte , Fletcher Claire

A key mechanism of persistent cell survival under testosterone suppression in advanced prostate cancer (PC) is continued Androgen Receptor (AR) activation. This results from AR mutation, overexpression, hyper-activation, and/or expression of constitutively-active AR transcript variants (AR-Vs). AR has an unusually long 3’ untranslated region (3’UTR), which performs vital regulatory roles but is remarkably understudied. Its contribution to continued AR activation unde...

ea0063p591 | Diabetes, Obesity and Metabolism 2 | ECE2019

A 5-years postoperative upper digestive endoscopy in obesity surgery

Benvenga Rosa , Catheline Jean Marc , Bendacha Yasmina , Cohen Regis

Introduction: Postoperative upper digestive endoscopy seems to give conflicting results in literature after obesity surgery. Some stressed on the frequency of major digestive lesions such as esophagitis, cancer or endo brachy esophagus (EBO) especially after Sleeve Gastrectomy (SG). The incidence of EBO after SG was found in 1.2% to 15% at ten years of follow up. Accordingly to European Guidelines, it is mandatory to perform a routinely preoperative gastroscopy but not after s...

ea0044p12 | Adrenal and Steroids | SFEBES2016

Characterization of adrenal-specific effects of ATR-101, a selective ACAT1 antagonist, in dogs

Hunt Stephen , Greenwood Krista , Reed Jessica , Heward Joseph , Bailie Marc

ATR-101 is a selective Acyl-CoA: cholesterol acyltransferase 1 (ACAT1) inhibitor in development for the treatment of diseases of the adrenal cortex including rare endocrine diseases, such as congenital adrenal hyperplasia (CAH) and Cushing’s syndrome (CS), and in adrenocortical carcinoma (ACC). ATR-101 has been shown to inhibit adrenal steroidogenesis at low doses and cause apoptosis at high doses. To better understand the adrenal-specific effects of ATR-101, in vivo<...

ea0041gp204 | Thyroid - Translational &amp; Clinical | ECE2016

Selenium supplementation and autoantibody titers in Graves’ disease

Faltado, Marc Antonio Jr , Yu Gregory , Rosario Acampado Laura

Background: Selenium (Se), a trace mineral with anti-oxidative properties, has been proposed to be potentially beneficial in patients with Graves’ disease (GD), especially those with active Graves’ ophthalmopathy (GO).Methods: Trials evaluating the efficacy of Se among non-pregnant adult GD patients with active GO, versus either placebo or an alternative drug, and on top of standard therapy, were included. A literature search was performed by t...

ea0041ep388 | Clinical case reports - Thyroid/Others | ECE2016

Acute mania after levothyroxine replacement for hypothyroid-induced heart block

Yu Marc Gregory , Flores Karen Marie , Isip-Tan Iris Thiele

Background: While psychiatric disturbances are well-documented manifestations of hypothyroidism, initiation of levothyroxine (LT4) therapy can also present in a similar manner.Case: A 34-year-old Filipino with Hashimoto’s thyroiditis consulted for signs and symptoms of hypothyroidism. Thyroid function tests were severely deranged, and an electrocardiogram revealed high grade atrioventricular block. Twenty-four hours after a full replaceme...

ea0035p611 | Endocrine tumours and neoplasia | ECE2014

TSH suppressive therapy accelerates progression of sacropenia in post-menopausal women

Diedhiou Demba , Klein Marc , Weryha Georges , Feigerlova Eva

Background: TSH-suppressive therapy in patients with differentiated thyroid carcinoma (DTC) leads to iatrogenic thyrotoxicosis and may be associated with alterations in body composition and bone mineral density (BMD). Its effects on a sarcopenia in elderly have not been in detail investigated.Objective: The objective was to compare changes in total and areal lean body mass (LBM), body fat mass (BFM) and BMD in postmenopausal female patients with DTC duri...

ea0034p215 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

The salt-inducible kinases: gatekeeper of hepatic gluconeogenesis

Patel Kashyap , Foretz Marc , Campbell David , Sutherland Calum , Sakamoto Kei

Regulation of hepatic gluconeogenesis by insulin and glucagon is central to blood glucose homeostasis. It has been proposed that the members of AMP-activated protein kinase (AMPK)-related kinases, the salt inducible kinase (SIK) isoforms, may play a role as signalling mediator in the control of insulin- and glucagon-regulated hepatic gluconeogenesis. However, the exact regulation and contribution of SIKs in hepatic gluconeogenesis is largely elusive. Here we employed selective...